Novel Metabolic Biomarkers and Therapeutic Strategies in Neurodegenerative Diseases-Reference-Cited by-同舟云学术

Novel Metabolic Biomarkers and Therapeutic Strategies in Neurodegenerative Diseases

Published:2024 Issue: Volume: Page:365-416
ISSN:
Container-title:Altered Metabolism: A Major Contributor of Comorbidities in Neurodegenerative Diseases
language:en
Short-container-title:

Author:

Thapliyal Anurag,Shweta ,Maurya Shashank Kumar

Publisher

Springer Nature Singapore

Link

https://link.springer.com/content/pdf/10.1007/978-981-97-4288-2_14

Reference258 articles.

1. Abe K, Itoyama Y, Sobue G, Tsuji S, Aoki M, Doyu M, Hamada C, Kondo K, Yoneoka T, Akimoto M, Yoshino H, Edaravone ALS Study Group (2014) Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener 15(7–8):610–617. https://doi.org/10.3109/21678421.2014.959024

2. Adil MM, Gaj T, Rao AT, Kulkarni RU, Fuentes CM, Ramadoss GN, Ekman FK, Miller EW, Schaffer DV (2018) hPSC-derived striatal cells generated using a scalable 3D hydrogel promote recovery in a Huntington disease mouse model. Stem Cell Rep 10(5):1481–1491. https://doi.org/10.1016/j.stemcr.2018.03.007

3. Ajitha A, Akhina H, Aswathi M, LovelyMathew P, Sabu T (2018) Carbon nanotubes: an ideal candidate for biomedical applications. JSM Nanotechnol Nanomed 6(2):1065–1075

4. Al Zweiri M, Sills GJ, Leach JP, Brodie MJ, Robertson C, Watson DG, Parkinson JA (2010) Response to drug treatment in newly diagnosed epilepsy: a pilot study of 1H NMR- and MS-based metabonomic analysis. Epilepsy Res 88(2):189–195. https://doi.org/10.1016/j.eplepsyres.2009.11.005

5. Al-Halifa S, Babych M, Zottig X, Archambault D, Bourgault S (2019) Amyloid self-assembling peptides: potential applications in nanovaccine engineering and biosensing. Pept Sci 111(1):e24095. https://doi.org/10.1002/pep2.24095